Lactobacillus johnsonii N6.2 Mitigates the Development of Type 1 Diabetes in BB-DP Rats
Ricardo Valladares(University of Florida), Graciela L. Lorca(University of Florida), Claudio F. González(University of Florida), Desmond Schatz(University of Florida), Mark A. Atkinson(University of Florida), Josef Neu(University of Florida), Clive Wasserfall(University of Florida), Joseph Larkin(University of Florida), Nan Li(Peking University), Dhyana Sankar(University of Florida), Kin-Kwan Lai(University of Florida), Eric W. Triplett(University of Florida), Emily A. Williams(University of Florida), Asmaa Sayed Abdelgeliel(South Valley University)
Cited by 287
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
Type 1 diabetes
|The Lancet|2013|2.7k
Pyrosequencing enumerates and contrasts soil microbial diversity
|The ISME Journal|2007|1.9k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k